The Trump administration’s FECA pharmacy benefit expansion 2026 federal workers compensation announcement has sent ripples through the federal employment and occupational health communities. In May 2026, the U.S. Department of Labor formally extended the Federal Employees’ Compensation Act (FECA) Pharmacy Benefit Program to cover claimants under the Black Lung Benefits Act, the Longshore and Harbor Workers’ Compensation Act (LHWCA), and the Energy Employees Occupational Illness Compensation Program Act — marking the most sweeping change to federal workers’ compensation pharmacy policy in more than five decades. For federal workers navigating medication costs after a workplace injury, this shift is significant, immediate, and worth understanding in full.
What Is the FECA Pharmacy Benefit Program — And Why Has It Just Expanded?
The Federal Employees’ Compensation Act, codified under 20 CFR Part 10, has governed how federal workers receive compensation for work-related injuries and illnesses since its modern form was established. However, the underlying federal workers’ compensation framework has not seen significant legislative amendment since 1974 — making the May 2026 announcement an extraordinarily rare regulatory development. The FECA Pharmacy Benefit Program was originally designed to streamline medication access for injured federal employees by creating a centralized, cost-controlled pharmacy network. Benefits are paid directly from the Employees’ Compensation Fund, ensuring consistent federal oversight of drug pricing and dispensing.
Prior to this expansion, the pharmacy benefit program applied exclusively to FECA-covered federal employees — those working in the executive, legislative, and judicial branches, as well as Peace Corps volunteers and federal jurors. The May 2026 rule change now brings additional and historically distinct populations under this umbrella: Black Lung Benefits Act claimants (coal miners suffering from occupational respiratory disease), LHWCA claimants (maritime and harbor workers injured in the course of maritime employment), and Energy Employees Occupational Illness Compensation Program Act claimants. The goal, according to the Department of Labor, is to improve drug pricing transparency and achieve measurable cost savings across all covered populations — a mission that the FECA program has already demonstrated is achievable, having reduced pharmacy drug spending by an remarkable 82.4%, from $226.2 million in 2018 to just $39.8 million in 2025.
Who Is Covered Under the FECA Pharmacy Benefit Expansion in 2026?
Understanding who qualifies under the FECA pharmacy benefit expansion 2026 federal workers compensation framework is essential for claimants, employers, and legal professionals alike. FECA’s core coverage has always been broad in scope but specific in definition. The program covers employees of the federal government’s three branches, Peace Corps workers, and individuals serving as federal jurors. Disability compensation is paid at a rate of 66⅔% of the worker’s pay when the injured employee has no dependents, rising to 75% when dependents are involved.
The May 2026 expansion adds previously underserved claimant groups to the pharmacy benefit structure. Black Lung claimants — coal miners and their survivors — have long operated under a separate benefit regime that lacked the integrated pharmacy cost controls of FECA. Effective May 15, 2026, the Black Lung program also implemented new pharmacy cards with electronic payment processing, modernizing how those claimants access medications at the point of sale. Similarly, Longshore and Harbor Workers’ Compensation Act claimants, who include dock workers, ship repairers, and maritime construction employees, previously faced fragmented pharmacy benefit access. The FECA pharmacy benefit expansion 2026 federal workers compensation rule unifies these groups under a single, federally managed pharmacy benefit structure for the first time.
Key Statistics: Federal Workers’ Compensation at a Glance (2026)
To appreciate the scale and significance of the 2026 pharmacy benefit expansion, it helps to view it alongside the broader federal workers’ compensation landscape. The FECA program’s track record on drug cost containment is particularly striking. According to the OWCP Annual Report to Congress published in 2026, the FECA program spent just $43.2 million on medications in 2024 — the lowest amount in over a decade. That figure represents a dramatic 82.4% reduction from the $226.2 million spent in 2018, as confirmed by the U.S. Department of Labor in May 2026. These savings were achieved through centralized pharmacy network management, formulary controls, and aggressive drug pricing negotiations — precisely the tools that will now be extended to Black Lung, LHWCA, and Energy Employees claimants.
On the broader workers’ compensation settlement front, 2026 data from WorkCompCalc shows the national average workers’ compensation settlement sits at approximately $29,750. However, that figure masks enormous variation: minor fractures may resolve for as little as $3,000, while catastrophic injuries — those involving permanent disability, traumatic brain injury, or spinal cord damage — can exceed $500,000. For federal workers specifically, FECA’s structured benefit formula provides a more predictable compensation path than the state workers’ comp system, though the stakes for getting pharmacy coverage right remain just as high.
How Does the Expansion Change Medication Cost Coverage and Reporting?
Before May 2026, Black Lung and LHWCA claimants accessed prescription medications through a patchwork of arrangements that often resulted in higher out-of-pocket costs, inconsistent formulary access, and limited price controls. The FECA Pharmacy Benefit Program’s centralized network eliminates much of that fragmentation. Under the expanded program, covered claimants present a pharmacy benefit card — now issued with electronic payment processing capabilities for Black Lung claimants as of May 15, 2026 — at any participating pharmacy, and medication costs are billed directly to the federal program rather than routed through the claimant.
From a reporting and oversight standpoint, the expansion also increases the federal government’s visibility into drug utilization patterns across previously siloed benefit programs. The OWCP will now collect standardized pharmacy claims data from Black Lung, LHWCA, and Energy Employees populations — data that has historically been difficult to aggregate. This improved data collection is expected to support further cost-reduction measures in future years, building on the momentum that brought FECA’s own medication spending to a decade-plus low of $43.2 million in 2024.
What the May 2026 DOL Action Means for Federal Claims Processing
The Department of Labor’s May 2026 action is not merely a policy announcement — it carries immediate operational consequences for claims processing across multiple federal compensation programs. For LHWCA claimants, the integration into the FECA pharmacy network means that authorized treating physicians can now prescribe covered medications with the expectation that the pharmacy benefit card system will handle adjudication directly. The elimination of paper-based reimbursement requests for routine prescriptions is expected to reduce administrative burden significantly for both claimants and district office staff.
For Black Lung claimants, the combination of pharmacy network integration and the new electronic payment processing cards introduced on May 15, 2026, represents a two-pronged modernization of what had been one of the most administratively cumbersome benefit delivery systems in federal workers’ compensation. The DOL’s Division of Coal Mine Workers’ Compensation has indicated that existing claimants will receive updated pharmacy cards and transition guidance, minimizing disruption to ongoing prescription access during the changeover period.
Looking Ahead: What Federal Workers Should Do Now
Whether you are a FECA-covered federal employee, a coal miner with an active Black Lung claim, a maritime worker covered under the LHWCA, or an Energy Employees Occupational Illness Compensation Program Act claimant, the May 2026 expansion has practical implications you should act on promptly. First, confirm with your OWCP district office or authorized representative that your claim file reflects your current covered status under the expanded pharmacy benefit program. Second, ensure that your treating physician is aware of the updated pharmacy benefit card system so that prescriptions are routed correctly from the outset.
If you are in the process of filing a new claim or negotiating a settlement, keep in mind that pharmacy benefit access is distinct from — but related to — your overall compensation package. With national average workers’ comp settlements sitting at approximately $29,750 in 2026 and catastrophic injury settlements potentially exceeding $500,000, ensuring that ongoing medication costs are covered through the federal pharmacy program rather than folded into a lump-sum settlement can have significant long-term financial consequences. Consulting with a workers’ compensation attorney who is familiar with both FECA and the applicable specialty statutes is strongly advisable before making any settlement decisions.
Frequently Asked Questions About the FECA Pharmacy Benefit Expansion 2026
What is the FECA pharmacy benefit expansion 2026 and who does it affect?
The FECA pharmacy benefit expansion 2026 refers to the U.S. Department of Labor’s May 2026 decision to extend the Federal Employees’ Compensation Act Pharmacy Benefit Program to claimants under the Black Lung Benefits Act, the Longshore and Harbor Workers’ Compensation Act, and the Energy Employees Occupational Illness Compensation Program Act. Previously, the program served only core FECA-covered federal employees. The expansion affects coal miners with occupational respiratory disease, maritime and harbor workers, and energy workers with qualifying occupational illnesses, giving them access to the same centralized, cost-controlled pharmacy network that has helped reduce FECA medication spending by 82.4% since 2018.
How does the FECA pharmacy benefit expansion 2026 change medication costs for Black Lung and LHWCA claimants?
Prior to May 2026, Black Lung and LHWCA claimants typically navigated fragmented pharmacy benefit arrangements with limited federal price controls. Under the expanded FECA pharmacy benefit program, these claimants now receive pharmacy benefit cards — including new electronic payment processing cards for Black Lung claimants effective May 15, 2026 — that allow prescriptions to be billed directly to the federal program at negotiated rates. This eliminates most out-of-pocket medication costs and removes the need for paper-based reimbursement claims for routine prescriptions, bringing their experience in line with the streamlined system that has driven FECA’s own drug spending to its lowest level in over a decade.
Has FECA been changed significantly before the 2026 expansion?
FECA’s core legislative framework has remained largely unchanged since 1974, making the May 2026 pharmacy benefit expansion a genuinely rare and significant development in federal workers’ compensation policy. While administrative updates and regulatory adjustments have occurred over the decades, the extension of the pharmacy benefit program to Black Lung, LHWCA, and Energy Employees claimants represents the broadest structural change to federal pharmacy benefit coverage in more than fifty years. The scale of the cost savings already achieved — $226.2 million in pharmacy spending in 2018 reduced to $39.8 million in 2025 — underscores why policymakers pursued the expansion.
What disability rates does FECA provide, and are those changing under the 2026 expansion?
FECA provides disability compensation at 66⅔% of the injured worker’s pay for employees without dependents, and 75% for those with dependents. These compensation rates are not changing under the May 2026 pharmacy benefit expansion. The expansion is specifically limited to the pharmacy benefit component of covered programs — it addresses how medications are accessed and paid for, not the underlying wage-replacement formula. Workers covered under the Black Lung Benefits Act and LHWCA continue to have their disability compensation determined by the rules specific to those statutes; the FECA pharmacy network integration is additive rather than a replacement of existing benefit structures.
What should LHWCA and Black Lung claimants do immediately following the May 2026 expansion?
LHWCA and Black Lung claimants should take several immediate steps following the May 2026 expansion. First, contact your OWCP district office to confirm that your claim is enrolled in the expanded pharmacy benefit program and that updated pharmacy benefit cards have been issued or are in process. Black Lung claimants should specifically inquire about the new electronic payment processing cards introduced on May 15, 2026. Second, notify your authorized treating physician of the change so that future prescriptions are directed through the new system. Third, if you are considering a workers’ compensation settlement — noting that national average settlements run approximately $29,750 in 2026, with catastrophic cases exceeding $500,000 — consult a qualified attorney before agreeing to terms, as ongoing pharmacy benefit access through the federal program may be more valuable long-term than folding medication costs into a one-time lump sum.
David Prescott is a Workers Rights and Injury Specialist with extensive knowledge of personal injury law and settlement values across the United States. With years of experience analyzing workplace injury claims only cases, David helps injury victims understand their legal rights and the potential value of their claims. David is not an attorney and the information provided is for educational purposes only.